Woodline Partners LP - REVOLUTION MEDICINES INC ownership

REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 222 filers reported holding REVOLUTION MEDICINES INC in Q2 2024. The put-call ratio across all filers is 0.53 and the average weighting 1.0%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of REVOLUTION MEDICINES INC
ValueSharesWeighting
Q2 2024$127,715,599
+4.4%
3,290,791
-13.3%
1.22%
+8.3%
Q1 2024$122,382,080
+44.2%
3,797,148
+28.3%
1.13%
+22.0%
Q4 2023$84,893,947
-2.5%
2,960,040
-5.9%
0.92%
-9.6%
Q3 2023$87,065,918
-13.5%
3,145,445
-16.4%
1.02%
-14.4%
Q2 2023$100,616,781
+35.7%
3,761,375
+9.9%
1.19%
+18.2%
Q1 2023$74,141,574
+591.7%
3,422,972
+660.6%
1.01%
+605.6%
Q4 2022$10,719,357
-3.6%
450,015
-20.2%
0.14%
-7.7%
Q3 2022$11,120,000
+116.3%
563,881
+113.8%
0.16%
+96.2%
Q2 2022$5,141,000
-91.4%
263,799
-88.7%
0.08%
-91.8%
Q1 2022$59,474,000
-19.4%
2,331,395
-20.4%
0.96%
-8.6%
Q4 2021$73,749,000
+208.3%
2,930,038
+237.0%
1.06%
+170.1%
Q3 2021$23,920,000
-11.5%
869,484
+2.1%
0.39%
-22.4%
Q2 2021$27,030,000
-30.0%
851,592
+1.1%
0.50%
-41.2%
Q1 2021$38,634,000
+20.9%
842,062
+4.3%
0.86%
+1.2%
Q4 2020$31,954,000
+3190.8%
807,130
+2791.8%
0.85%
+2546.9%
Q3 2020$971,000
-19.2%
27,911
-49.1%
0.03%
-62.8%
Q1 2020$1,202,00054,8670.09%
Other shareholders
REVOLUTION MEDICINES INC shareholders Q2 2024
NameSharesValueWeighting ↓
TRV GP II, LLC 1,909,317$66,444,00043.13%
TRV GP III, LLC 8,024,031$279,236,00023.46%
Svennilson Peter 7,977,384$277,613,00022.65%
TRV GP IV, LLC 1,419,900$49,413,00017.01%
Trustees of Princeton University 90,758$3,158,0004.22%
BVF INC/IL 2,101,049$73,117,0003.98%
Boxer Capital, LLC 3,309,264$115,162,0003.98%
Cormorant Asset Management, LP 2,640,177$91,878,0003.53%
Copernicus Capital Management, LLC 81,000$2,819,0002.68%
Casdin Capital, LLC 1,634,535$56,882,0002.55%
View complete list of REVOLUTION MEDICINES INC shareholders